Weight-Loss Medications
Last Updated: Friday, 07 August 2026Please find information on GLP1 prescribing via NHS route. ICB website provides relevant national guidance around who is eligible for this programme. All patients must first adhere to strict criteria in order to be referred , which includes https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/
- high blood pressure (hypertension)
- heart disease (cardiovascular disease)
- obstructive sleep apnoea (and on CPAP)
- abnormal blood fats (dyslipidaemia)
NICE has committed to reviewing access criteria after year 3 to evaluate the implementation and delivery of Tirzepatide.
Further details on the prioritisation of availability of Tirzepatide can be found in the NHS England » Medicines for obesity